Replies to post #385276 on Elite Pharmaceuticals Inc (ELTP)

[The ELTP King]

Why you leaving out Vigabatrin which is ALREADY approved and is LAUNCHING by the end of THIS year.

And probably an approval of the dopamine agonist in October? Filed 12/22/22 or thereabouts. Not a needle mover but every bit helps.

My guess would be if approved in Oct/Nov 2023, maybe launch in Jan/Feb 2024?

https://elite.irpass.com/Elite-Pharmaceuticals-Files-ANDA-with-US-FDA-to-Market-Dopamine-Agonist-12-22-2022